Skip to content

American Journal of Psychiatry

ISSN 0002-953X, 1535-7228

132 papers in the library · 19,379 citations · publishing 1948-2026

Papers

Sort Most recent Most cited

Ketamine for rapid reduction of suicidal thoughts in major depression: a midazolam-controlled randomized clinical trial

American Journal of Psychiatry December 5, 2017 Michael F Grunebaum, Hanga C Galfalvy, Tse-Hwei Choo et al. 428 citations

Objective Pharmacotherapy to rapidly relieve suicidal ideation in depression may reduce suicide risk. Rapid reduction in suicidal thoughts after ketamine treatment has mostly been studied in patients with low levels of suicidal ideation. Method This randomized clinical trial tested the effect of adjunctive sub-anesthetic intravenous ketamine on clinically significant suicidal ideation in major...

The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis

American Journal of Psychiatry October 3, 2017 S. Wilkinson, Elizabeth D. Ballard, Michael H. Bloch et al. 680 citations

Objective Suicide is a public health crisis with limited treatment options. We conducted a systematic review and individual participant data meta-analysis examining the effects of a single dose of ketamine on suicidal ideation. Method Individual participant data were obtained from 10 of 11 identified comparison intervention studies (using either saline or midazolam as control). The analysis...

A survey of the clinical, off-label use of ketamine as a treatment for psychiatric disorders

American Journal of Psychiatry July 1, 2017 S. T. Wilkinson, Mesut Toprak, Mason S. Turner et al.

TO THE EDITOR: Since 2000, several small randomized controlled trials have demonstrated that ketamine has potent and rapid-acting antidepressant effects in patients with treatment-resistant depression (1). Despite a lack of longterm data or Food and Drug Administration indication, many community providers and academic centers have begun offering ketamine treatment to patients with major...

Cannabis, Psychosis, and Mortality: A Cohort Study of 50,373 Swedish Men.

American Journal of Psychiatry August 1, 2016 Edison Manrique-Garcia, Antonio Ponce de Leon, Christina Dalman et al.

The authors assessed 1) the overall risk of death among cannabis users compared with nonusers and the extent to which psychosis affects excess mortality; 2) mortality among persons with psychotic disorders and the extent to which cannabis use affects excess mortality; and 3) the interaction effect of cannabis use and diagnosis of psychotic disorders on mortality. This was a longitudinal study...

A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression

American Journal of Psychiatry April 8, 2016 Jaskaran Singh, Maggie Fedgchin, Ella Daly et al. 530 citations

OBJECTIVE: Ketamine, an N-methyl-d-aspartate glutamate receptor antagonist, has demonstrated a rapid-onset antidepressant effect in patients with treatment-resistant depression. This study evaluated the efficacy of twice- and thrice-weekly intravenous administration of ketamine in sustaining initial antidepressant effects in patients with treatment-resistant depression. METHOD: In a...

Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression

American Journal of Psychiatry October 1, 2015 D. Jeffrey Newport, Linda L. Carpenter, William M. Mcdonald et al. 594 citations

OBJECTIVE: The authors conducted a systematic review and meta-analysis of ketamine and other N-methyl-d-aspartate (NMDA) receptor antagonists in the treatment of major depression. METHOD: Searches of MEDLINE, PsycINFO, and other databases were conducted for placebo-controlled, double-blind, randomized clinical trials of NMDA antagonists in the treatment of depression. Primary outcomes were...

Repeated Δ9-tetrahydrocannabinol exposure in adolescent monkeys: persistent effects selective for spatial working memory.

American Journal of Psychiatry April 2014 Christopher D. Verrico, Hong Gu, Melanie L Peterson et al.

Epidemiological findings suggest that, relative to adults, adolescents are more vulnerable to the adverse persistent effects of cannabis on working memory. However, the potential confounds inherent in human studies preclude direct determination of a cause-and-effect relationship between adolescent cannabis use and heightened susceptibility to persistent working memory impairments. Consequently,...

Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial

American Journal of Psychiatry August 28, 2013 James W. Murrough, Dan V. Iosifescu, Lee C. Chang et al. 1,207 citations

OBJECTIVE: Ketamine, a glutamate N-methyl-d-aspartate (NMDA) receptor antagonist, has shown rapid antidepressant effects, but small study groups and inadequate control conditions in prior studies have precluded a definitive conclusion. The authors evaluated the rapid antidepressant efficacy of ketamine in a large group of patients with treatment-resistant major depression. METHOD: This was a...

Relations of Pre-Onset Cannabis, Alcohol, and Tobacco Use with the Age at Onset of Prodrome and Age at Onset of Psychosis in First-Episode Patients

American Journal of Psychiatry October 1, 2009 Michael T Compton, M. Kelley, Claire E. Ramsay et al.

Objective Several reports suggest that cannabis use is associated with an earlier age at onset of psychosis, though not all studies have operationalized cannabis use as occurring prior to onset of symptoms. This study addressed whether pre-onset cannabis use (and alcohol and tobacco use) is associated with an earlier age at onset of prodromal and psychotic symptoms. Additionally, effects of the...

Psychophysiological evidence of altered neural synchronization in cannabis use: relationship to schizotypy.

American Journal of Psychiatry October 2006 Patrick D. Skosnik, Giri P Krishnan, Erin E Aydt et al.

Cannabis use may produce neurophysiological disturbances similar to those observed in schizophrenia, particularly in relation to altered neural synchronization. Therefore, the current experiment examined the effect of cannabis use on EEG neural synchronization using the auditory steady-state evoked potential. Auditory steady-state evoked potentials were assessed using varying rates of...

Altered NMDA Glutamate Receptor Antagonist Response in Individuals With a Family Vulnerability to Alcoholism

American Journal of Psychiatry October 1, 2004 Ismene L. Petrakis, Diana Limoncelli, Ralitza Gueorguieva et al. 143 citations

OBJECTIVE: A family history of alcoholism is a risk factor for the development of ethanol dependence. Ethanol is an antagonist of the N-methyl-d-aspartate (NMDA) glutamate receptor, and alterations in NMDA receptor function are thought to be involved in ethanol abuse and dependence. The purpose of this study was to determine in healthy individuals with no ethanol dependence whether response to...

DOI: 10.1176/ajp.161.10.1776 (opens in new tab) Nmda receptor Glutamate receptor Antagonist Vulnerability computing +2

A Voxel-Based PET Investigation of the Long-Term Effects of “Ecstasy” Consumption on Brain Serotonin Transporters

American Journal of Psychiatry July 1, 2004 Ralph Buchert, Rainer Thomasius, Florian Wilke et al. 183 citations

These findings support the hypothesis of MDMA-induced protracted alterations of the serotonergic system and indicate that the reduced availability of serotonin transporter, as measured by PET, might be reversible. Women appear to be more susceptible than men to MDMA-induced alterations of the serotonergic system.

The Serotonin System and Spiritual Experiences

American Journal of Psychiatry November 1, 2003 Jacqueline Borg, Bengt Andrée, Henrik Söderström et al. 247 citations

OBJECTIVE: The serotonin system has long been of interest in biological models of human personality. The purpose of this positron emission tomography (PET) study was to search for relationships between serotonin 5-HT(1A) receptor density and personality traits. METHOD: Fifteen normal male subjects, ages 20-45 years, were examined with PET and the radioligand [(11)C]WAY100635. Personality traits...

DOI: 10.1176/appi.ajp.160.11.1965 (opens in new tab) Serotonin Temperament Self-transcendence Radioligand +5

Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia.

American Journal of Psychiatry 2003 Shitij Kapur 2,813 citations

Objective: The clinical hallmark of schizophrenia is psychosis. The objective of this overview is to link the neurobiology (brain), the phenomenological experience (mind), and pharmacological aspects of psychosis-in-schizophrenia into a unitary framework. Method: Current ideas regarding the neurobiology and phenomenology of psychosis and schizophrenia, the role of dopamine, and the mechanism of...

DOI: 10.1176/appi.ajp.160.1.13 (opens in new tab) Brain Humans Hallucinations Dopamine +7

Electrophysiological Evidence of Serotonergic Impairment in Long-Term MDMA (“Ecstasy”) Users

American Journal of Psychiatry October 1, 2001 Rodney J. Croft, A. Klugman, Torsten Baldeweg et al. 100 citations

These data show that 5-HT dysfunction occurs in MDMA users, is related to users' MDMA consumption, and is independent of cannabis use. The results do not suggest that self-medication explains this relationship, because the deficit was related to total MDMA consumption but not frequency of consumption. The results are thus consistent with the thesis that MDMA consumption causes 5-HT impairment...

A psychiatric dialogue on the mind-body problem.

American Journal of Psychiatry July 1, 2001 K S Kendler

Of all the human professions, psychiatry is most centrally concerned with the relationship of mind and brain. In many clinical interactions, psychiatrists need to consider both subjective mental experiences and objective aspects of brain function. This article attempts to summarize, in the form of a dialogue between a philosophically informed attending psychiatrist and three residents, the...

MDMA (“Ecstasy”) Abuse and High-Risk Sexual Behaviors Among 169 Gay and Bisexual Men

American Journal of Psychiatry July 1, 2000 Robert Klitzman, Harrison G. Pope, James I. Hudson 132 citations

OBJECTIVE: The authors explored the association between abuse of 3,4-methylenedioxymethamphetamine (MDMA, or “Ecstasy”) and high-risk sexual behaviors among gay and bisexual men. METHOD: An anonymous questionnaire was completed by 169 gay and bisexual men at three New York City dance clubs. The questionnaire covered demographic indices, use of MDMA and other drugs, and history of high-risk...

DOI: 10.1176/appi.ajp.157.7.1162 (opens in new tab) Ecstasy MDMA Ethnic group Association psychology +7

The contribution of Hughlings Jackson to an understanding of dissociation.

American Journal of Psychiatry December 1, 1999 R Meares

The author provides a preliminary framework for a systematic and dynamic understanding of dissociation through a consideration of the theories of Hughlings Jackson. Jackson's ideas are briefly reviewed. He saw the proper scientific investigation of mental illness as an experimental investigation of mind. Accordingly, his argument begins with this fundamental concept. His views of the brain-mind...

Hypnotizability and traumatic experience: a diathesis-stress model of dissociative symptomatology.

American Journal of Psychiatry July 1, 1996 Lisa D Butler, R E Duran, P Jasiukaitis et al.

Objective: The authors propose a diathesis-stress model to describe how pathological dissociation may arise from an interaction between innate hypnotizability and traumatic experience. Method: To support the proposition that pathological dissociation may reflect autohypnotic process, the authors highlight clinical and research data indicating parallels between controlled hypnotic dissociative...

DOI: 10.1176/ajp.153.8.a42 (opens in new tab) Full text (opens in new tab) Humans Amnesia Disease susceptibility Hypnosis +15

Sleep events among veterans with combat-related posttraumatic stress disorder.

American Journal of Psychiatry January 1995 T A Mellman, R Kulick-Bell, L E Ashlock et al.

Sleep disturbances are important features of posttraumatic stress disorder (PTSD); however, the published data characterizing PTSD sleep phenomena are limited. The authors report on the phenomenology and physiological correlates of symptomatic sleep events in PTSD. The study data included survey results that addressed sleep symptoms during the past month in combat veterans with and without PTSD...

Effectiveness of a meditation-based stress reduction program in the treatment of anxiety disorders

American Journal of Psychiatry July 1, 1992 1,950 citations

OBJECTIVE: This study was designed to determine the effectiveness of a group stress reduction program based on mindfulness meditation for patients with anxiety disorders. METHOD: The 22 study participants were screened with a structured clinical interview and found to meet the DSM-III-R criteria for generalized anxiety disorder or panic disorder with or without agoraphobia. Assessments,...

Recent advances in the phencyclidine model of schizophrenia

American Journal of Psychiatry October 1, 1991 2,916 citations

OBJECTIVE: Phencyclidine (PCP, "angel dust") induces a psychotomimetic state that closely resembles schizophrenia. As opposed to amphetamine-induced psychosis, PCP-induced psychosis incorporates both positive (e.g., hallucinations, paranoia) and negative (e.g., emotional withdrawal, motor retardation) schizophrenic symptoms. PCP-induced psychosis also uniquely incorporates the formal thought...

Dream process in asthmatic subjects with nocturnal attacks

American Journal of Psychiatry May 1, 1987 Jane Clements Monday, Jacques Montplaisir, Jean‐Luc Malo 23 citations

Polygraphic sleep recordings were made and dream reports collected over 3 consecutive nights for 12 asthmatic subjects with nocturnal attacks and 12 matched normal control subjects. The asthmatic group 1) had more episodes of a vivid impression of dreaming without recollection of dream content ("white dreams") after awakening spontaneously in the morning (nights 1 and 2) and after awakening...